Scarica l'app Stockscreener
0.1807
21.16%
-0.0485
Pre-mercato:
.17
-0.0107
-5.92%
Co Diagnostics Inc Borsa (CODX) Ultime notizie
Institution Moves: Is Co Diagnostics Inc stock a buy in volatile marketsDip Buying & Daily Volume Surge Trade Alerts - moha.gov.vn
Co-Diagnostics (CODX) Announces 1-for-30 Reverse Stock Split - GuruFocus
Co-Diagnostics to Effect a 1-for-30 Reverse Stock Split - marketscreener.com
CODX stock plunges to all-time lows on 1-for-30 reverse stock split approval - MSN
CODX Stock Plunges To All-Time Lows On 1-for-30 Reverse Stock Split Approval - Stocktwits
Co-Diagnostics announces 1-for-30 reverse stock split By Investing.com - Investing.com Nigeria
Co-Diagnostics stock plunges after announcing 1-for-30 reverse split By Investing.com - Investing.com Australia
Co-Diagnostics stock plunges after announcing 1-for-30 reverse split - Investing.com UK
Co-Diagnostics Approves Reverse Stock Split to Maintain Listing - TipRanks
Biotech Co-Diagnostics shrinks share count 30-to-1 to stay on Nasdaq - Stock Titan
Co-Diagnostics (CODX) Secures Australian Patent for PCR Platform - GuruFocus
Co-diagnostics receives Australian patent for PCR testing platform By Investing.com - Investing.com India
Co-diagnostics receives Australian patent for PCR testing platform - Investing.com Australia
New point-of-care PCR tech for flu and COVID secures patent in Australia - Stock Titan
Co-Diagnostics Q3 2025 Earnings Preview - MSN
Aug Breakouts: How resilient is Co Diagnostics Inc. stock in market downturns - Улправда
Can Co Diagnostics Inc. stock sustain market leadershipWeekly Trade Report & Low Drawdown Momentum Trade Ideas - Улправда
Why Co Diagnostics Inc. stock is seen as undervaluedJuly 2025 Update & Stepwise Trade Signal Guides - Улправда
Will Co Diagnostics Inc. stock deliver consistent dividends2025 Support & Resistance & Free High Accuracy Swing Entry Alerts - DonanımHaber
Can Co Diagnostics Inc. stock weather global recession2025 Trading Volume Trends & Reliable Price Breakout Signals - ulpravda.ru
Bond Watch: Is Co Diagnostics Inc. stock a buy in volatile markets2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - DonanımHaber
How resilient is Co Diagnostics Inc. stock in market downturnsPortfolio Risk Summary & AI Forecast Swing Trade Picks - Улправда
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in - GuruFocus
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India - Financial Times
Inside a global effort to improve TB testing across South Asia this week - Stock Titan
Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Con - GuruFocus
Co-Diagnostics (CODX) Validates Efficacy of Influenza and COVID-19 Detection Test - GuruFocus
Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation - Barchart.com
Flu mutation raises worries — this PCR test still flags H3N2 cases - Stock Titan
Co Diagnostics Inc Stock Analysis and ForecastRisk Mitigation Techniques & Affordable Trading Techniques - earlytimes.in
Certain Warrants of Co-Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 14-DEC-2025. - marketscreener.com
Certain Restricted Stock Units of Co-Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 14-DEC-2025. - marketscreener.com
Certain Stock Options of Co-Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 14-DEC-2025. - marketscreener.com
48,142,582 Common Stock of Co-Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 14-DEC-2025. - marketscreener.com
Value Recap: Will Co Diagnostics Inc stock deliver consistent dividendsMarket Growth Summary & High Accuracy Swing Entry Alerts - moha.gov.vn
Co-Diagnostics, Arabian Eagle to Develop and Commercialize Co-Dx Tech - Medical Product Outsourcing
Co-Diagnostics Earnings Call: Strategic Moves Amid Financial Struggles - MSN
CapEx per share of Co-Diagnostics, Inc. – MUN:C97 - TradingView — Track All Markets
Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025 - Barchart.com
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pun - GuruFocus
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India - Sahm
Co-Diagnostics (Nasdaq: CODX) JV highlights TB, HPV PoC tests at VIROCON 2025 - Stock Titan
Co-Diagnostics (CODX) price target decreased by 37.50% to 1.28 - MSN
Co-Diagnostics approves reverse stock split proposal - MSN
Co-Diagnostics Approves Reverse Stock Split Proposal - TipRanks
CoDiagnostics (CODX) Upgraded to Buy: Here's What You Should Know - MSN
Co-Diagnostics (CODX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Operating cash flow per share of Co-Diagnostics, Inc. – HAN:C97 - TradingView
Profit Review: Is Co Diagnostics Inc. stock attractive for retirement portfoliosTrade Exit Report & Verified Momentum Stock Alerts - BỘ NỘI VỤ
Is Co Diagnostics Inc. a good long term investmentContrarian Investment Ideas & Build Wealth Brick by Brick With Us - earlytimes.in
Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results (PR Newswire) - Aktiellt
Maxim Group initiates coverage on Co-Diagnostics stock with Buy rating - Investing.com Canada
Maxim Group Initiates Coverage of Co-Diagnostics (CODX) with Buy Recommendation - Nasdaq
Co-Diagnostics (CODX) Initiated with 'Buy' Rating by Maxim Group - GuruFocus
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
HC Wainwright & Co. Reiterates Co-Diagnostics (CODX) Neutral Recommendation - MSN
[Form 4] Co-Diagnostics, Inc. Insider Trading Activity - Stock Titan
0.11%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):